
Filament Health ships psilocybin drug PEX010 to Australia for first trial combining psychedelics with physiotherapy in movement disorders.
Filament Health has shipped its patented psilocybin drug candidate PEX010 to Austin Health in Melbourne for the PSI-PHY trial, the first study to combine psilocybin-assisted physiotherapy for refractory motor functional neurological disorder (FND). S...


